Detection of peripheral artery disease in patients with ischemic heart disease. A quick guide for medical practitioners
https://doi.org/10.18087/cardio.2020.12.n1380
Abstract
In this manual, the authors focused on the principal methods for diagnosis of peripheral artery disease in cardiological patients, from the interview and physical examination to functional tests and vascular visualization. Diagnostic and prognostic value of each method, its potentialities for reducing the risk of cardiovascular events (CVE), including myocardial infarction (MI), ischemic stroke (IS) or extremity amputation in critical ischemia, and overall mortality are discussed. The authors provided current information about a possibility of reducing the risk of CVE by intensifying the antithrombotic therapy according to results of the COMPASS study.
Keywords
Multifocal atherosclerosis,
coronary atherosclerosis,
peripheral arterial disease,
lower extremity arterial disease,
chronic coronary syndrome
Supporting agencies: Conflict of interest: D.P. Dundua is an expert of the companies Astra Zeneca, Bayer, Boehringer Ingelheim, and Sanofi; I.D. Strazhesko is a participant of the COMPASS study and an expert of the companies Bayer and Sanofi. The publication was prepared with the support of Bayer JSC, which in no way influenced the opinion of the authors.
About the Authors
D. P. Dundua
Scientific and Clinical Center of The Federal Mediacal and Biological Agency of Russia, Moscow
Russian Federation
Russian Federation
MD, PhD
Head of cardiology center of the Scientific and Clinical Center of The Federal Mediacal and Biological Agency of Russia
I. D. Strazhesko
Russian Clinical and Research Center of Gerontology, Moscow, Russia
Russian Federation
Russian Federation
MD, PhD
Vice director of the Russian Clinical and Research Center of Gerontology
References
1.
2. Bokeria L.A., Pokrovskiy A.V., Akchurin R.S., Alekyan B.G., Apkhanova T.V., Arakelyan V.S. et al. National guidelines for the diagnosis and treatment of lower limb artery diseases. Moscow. Av. at: http://www.angiolsurgery.org/library/recommendations/2019/recommendations_LLA_2019. pdf. 2019.
3. Jernberg T, Hasvold P, Henriksson M, Hjelm H, Thuresson M, Janzon M. Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. European Heart Journal. 2015;36(19):1163–70. DOI: 10.1093/eurheartj/ehu505
4. Froehlich JB, Mukherjee D, Avezum A, Budaj A, Kline-Rogers EM, López-Sendón J et al. Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). American Heart Journal. 2006;151(5):1123–8. DOI: 10.1016/j.ahj.2005.11.005
5. Aboyans V, Ricco J-B, Bartelink M-LEL, Björck M, Brodmann M, Cohnert T et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). European Heart Journal. 2018;39(9):763–816. DOI: 10.1093/eurheartj/ehx095
6. Weitz JI, Byrne J, Clagett GP, Farkouh ME, Porter JM, Sackett DL et al. Diagnosis and Treatment of Chronic Arterial Insufficiency of the Lower Extremities: A Critical Review. Circulation. 1996;94(11):3026–49. DOI: 10.1161/01.CIR.94.11.3026
7. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE et al. Ankle Brachial Index Combined with Framingham Risk Score to Predict Cardiovascular Events and Mortality: A Meta-analysis. JAMA. 2008;300(2):197–208. DOI: 10.1001/jama.300.2.197
8. Criqui MH, McClelland RL, McDermott MM, Allison MA, Blumenthal RS, Aboyans V et al. The Ankle-Brachial Index and Incident Cardiovascular Events in the MESA (Multi-Ethnic Study of Atherosclerosis). Journal of the American College of Cardiology. 2010;56(18):1506–12. DOI: 10.1016/j.jacc.2010.04.060
9. Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O et al. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. New England Journal of Medicine. 2017;377(14):1319–30. DOI: 10.1056/NEJMoa1709118
10. Bhatt DL, Eagle KA, Ohman EM, Hirsch AT, Goto S, Mahoney EM et al. Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis. JAMA. 2010;304(12):1350–7. DOI: 10.1001/jama.2010.1322
11. Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC et al. Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction. New England Journal of Medicine. 2015;372(19):1791–800. DOI: 10.1056/NEJMoa1500857
12. Bhatt DL, Fox KAA, Hacke W, Berger PB, Black HR, Boden WE et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. The New England Journal of Medicine. 2006;354(16):1706–17. DOI: 10.1056/NEJMoa060989
13. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, FunckBrentano C et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal. 2020;41(3):407–77. DOI: 10.1093/eurheartj/ehz425
14. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE et al. 2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135(12):686–725. DOI: 10.1161/CIR.0000000000000470
15. Patel A, Toole JF. Subclavian steal syndrome-reversal of cephalic blood flow. Medicine. 1965;44(4):289–303. DOI: 10.1097/00005792-196507000-00002
16. Saha T, Naqvi SY, Ayah OA, McCormick D, Goldberg S. Subclavian Artery Disease: Diagnosis and Therapy. The American Journal of Medicine. 2017;130(4):409–16. DOI: 10.1016/j.amjmed.2016.12.027
17. Chang JB. Textbook of Angiology. -New York: Springer New York;2000. – 1362 p. ISBN 978-1-4612-1190-7
18. Blut EI, Benson KB, Ralls FU, Sigel MJ. Ultrasound: A Practical Approach to Clinical Problems. Vol. 5. -M.: Medical literature;2011. –192 p. ISBN 978-5-89677-145-6
19. Horehledova B, Mihl C, Milanese G, Brans R, Eijsvoogel NG, Hendriks BMF et al. CT Angiography in the Lower Extremity Peripheral Artery Disease Feasibility of an Ultra-Low Volume Contrast Media Protocol. CardioVascular and Interventional Radiology. 2018;41(11):1751–64. DOI: 10.1007/s00270-018-1979-z
20. Alekyan B.G. Endovascular surgery: national guide. V. 3. Vascular, neurological, surgical, oncological, gynecological and urological diseases. – M.: Litterra;2017. – 595 p. ISBN 978-5-4235-0278-2
21. Lin A, Rawal S, Agid R, Mandell DM. Cerebrovascular Imaging: Which Test is Best? Neurosurgery. 2018;83(1):5–18. DOI: 10.1093/neuros/nyx325
22. Mega JL, Braunwald E, Wiviott SD, Bassand J-P, Bhatt DL, Bode C et al. Rivaroxaban in patients with a recent acute coronary syndrome. The New England Journal of Medicine. 2012;366(1):9–19. DOI: 10.1056/NEJMoa1112277
23. Aboyans V, Ricco J-B, Bartelink ML, Björck M, Brodmann M, Cohnert T et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Russian Journal of Cardiology. 2018;23(8):164–221. DOI: 10.15829/1560-4071-2018-8-164-221
Review
For citations:
Dundua D.P., Strazhesko I.D. Detection of peripheral artery disease in patients with ischemic heart disease. A quick guide for medical practitioners. Kardiologiia. 2020;60(12):125-132. (In Russ.) https://doi.org/10.18087/cardio.2020.12.n1380
Views:
1313
Email this article 
Post a Comment 
